LaparoscopicGallbladderRemovalCholecystectomy near Forest Hills, NY

Biography: Dr. Mark Reiner, MD is a General Surgery Specialist who practices in New York, NY. He is 76 years old and has been practicing for 51 years.

Biography: Dr. Llore is an Assistant Professor of Surgery at Columbia University and an Attending Transplant Surgeon at New York Presbyterian Hospital. Dr. Llore received her undergraduate degree from Fordham University and her medical degree from New York University School of Medicine. She completed general surgery residency at Georgetown University Hospital and abdominal transplant/hepatobiliary fellowship training at New York Presbyterian Columbia and Weill Cornell. She received additional training on the immune response after a liver transplant and xenotransplantation with Dr. Megan Sykes at Columbia Center for Translational Immunology (CCTI). She is board-certified in general surgery and received specialty training in abdominal transplant and hepatobiliary surgery. Her practice interests focus on the surgical management of children and adults with liver and bile duct disease, including benign and malignant liver tumors. She practices minimally invasive surgical techniques in liver surgery to shorten recovery times and reduce post operative discomfort. Dr. Llore is interested in surgical education and is the Associate Program Director for the ASTS certified surgical fellowship program.

Biography: Dr. McManus is a board-certified, high volume Endocrine surgeon who treats thyroid, parathyroid, and adrenal disease and serves as the Surgical Director of the Thyroid Biopsy Program. Her expertise in minimally invasive interventions, including thermal ablation of thyroid nodules and robotic adrenalectomy, allows her to provide individualized, high quality care to all of her patients. Dr. McManus earned a master's degree in Clinical Research Methods and has received national and international recognition for her work including the International Association of Endocrine Surgeons (IAES) Travel Scholar Award.

Biography: Dr. Sanghyun Kim, MD is a General Surgery Specialist who practices in Flushing, NY. He is 55 years old. Dr. Sanghyun Kim, MD is affiliated with Mount Sinai Hospital.

Biography: Dr. Emond is the Vice Chairman of Surgery at Columbia University. He has over 30 years of experience performing liver transplantation and complex liver and biliary surgery in children and adults, including the first living donor liver transplantation (LDLT) in the United States. Dr. Emond has published extensively in this field and was the co-chair of the NIH A2ALL program for 13 years. In collaboration with the department of Medicine at Columbia, Dr. Emond recruited the leadership of the Columbia Center for Translational immunology that created the foundation for translational and clinical research in transplantation tolerance. This will lead the way to inducing transplant tolerance in liver patients with the mixed chimerism strategy. As Director of Transplantation at the Columbia University Medical Center Dr. Emond's activities foster clinical excellence and research across all 11 of the solid organ transplant programs at the Medical Center. In recognition of his national and international leadership in transplantation, Dr. Emond is the past president of the American Society of Transplant Surgeons, the pre-eminent association of a transplant surgery. Contribution to Science Living donor liver transplantation Dr. Emond has spent a substantial portion of his career developing living donor liver transplantation and studying the safety of the procedure in both the donor and recipient. He participated in the first living donor liver transplant in the United States and focused on refining the techniques of performing living donor liver transplants and split liver transplants. He was the national co-chair of the NIH-sponsored Adult-to-Adult Living Donor Liver Transplantation (A2ALL) consortium from 2002 to 2015 to study the safety and outcomes of living donor liver transplants. Hepatic resection/ischemia Dr. Emond developed techniques for surgical resection of liver tumors and studied the effect of ischemia during resection on postoperative liver function. These studies include the outcomes of the extent of hepatectomy, the biochemical response to major hepatectomy and ischemia-reperfusion injury of the liver in rodent models. He has studied the clinical safety of inducing total vascular exclusion to provide a bloodless field during the liver transection. This has applications in both liver cancer and living donor hepatectomies. Hepatocellular carcinoma treatment Dr. Emond has studied many aspects of managing patients with hepatocellular carcinoma. These studies have included characterizing the risk factors for recurrence of disease following transplantation due to comorbidities and tumor characteristics. The research team has also studied the optimal method of preventing tumor growth in patients with HCC on the liver transplant wait list in addition to optimal strategies of liver allocation to optimize outcomes following liver transplantation. These studies have contributed to proposed changes in UNOS exception point allocation for liver transplant candidates with HCC. Pediatric liver transplantation Dr. Emond helped develop the field of pediatric liver transplantation. Contributions to this field include: the use of living donors for pediatric patients; use of auxiliary liver transplants for metabolic diseases; use of partial liver grafts for pediatric patients; and technical modifications that improved outcomes for this patient population. Visit The Center for Liver Disease and Transplantation at columbiasurgery.org/liver